|
J B Chemicals & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
34192.58 Cr.
|
P/BV
|
8.54
|
Book Value (Rs.)
|
249.38
|
|
52 Week High/Low (Rs.)
|
2285/1604
|
FV/ML
|
1/1
|
P/E(X)
|
48.19
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
44.19
|
Div Yield (%)
|
1.03
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 45.16 | 42.45 | 35.66 | 53.00 | 49.86 |
| Diluted EPS (Rs.) | 44.45 | 41.56 | 34.85 | 52.34 | 49.86 |
| Cash EPS (Rs.) | 55.54 | 53.36 | 44.52 | 67.77 | 59.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 258.98 | 220.54 | 188.36 | 320.55 | 276.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 258.98 | 220.54 | 188.36 | 320.55 | 276.73 |
| Revenue From Operations / Share (Rs.) | 258.27 | 251.67 | 224.50 | 407.00 | 313.69 |
| PBDIT / Share (Rs.) | 72.70 | 68.74 | 60.19 | 91.20 | 75.40 |
| PBIT / Share (Rs.) | 61.34 | 57.76 | 51.28 | 76.42 | 66.00 |
| PBT / Share (Rs.) | 59.30 | 57.00 | 48.42 | 71.76 | 65.33 |
| Net Profit / Share (Rs.) | 44.18 | 42.37 | 35.61 | 52.99 | 49.95 |
| NP After MI And SOA / Share (Rs.) | 44.18 | 42.37 | 35.61 | 52.97 | 49.86 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 28.14 | 27.31 | 26.81 | 22.40 | 24.03 |
| PBIT Margin (%) | 23.74 | 22.94 | 22.84 | 18.77 | 21.03 |
| PBT Margin (%) | 22.95 | 22.64 | 21.56 | 17.63 | 20.82 |
| Net Profit Margin (%) | 17.10 | 16.83 | 15.86 | 13.01 | 15.92 |
| NP After MI And SOA Margin (%) | 17.10 | 16.83 | 15.86 | 13.01 | 15.89 |
| Return on Networth / Equity (%) | 17.05 | 19.21 | 18.90 | 16.52 | 18.05 |
| Return on Capital Employeed (%) | 22.50 | 24.69 | 25.45 | 19.71 | 22.93 |
| Return On Assets (%) | 14.27 | 15.43 | 13.83 | 11.53 | 14.77 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.15 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.12 | 0.22 | 0.01 |
| Asset Turnover Ratio (%) | 0.89 | 0.94 | 0.92 | 1.02 | 0.91 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.98 | 3.04 | 2.13 | 2.76 | 3.32 |
| Quick Ratio (X) | 3.83 | 2.20 | 1.56 | 1.98 | 2.25 |
| Inventory Turnover Ratio (X) | 6.84 | 7.60 | 1.75 | 1.87 | 1.73 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 35.93 | 28.40 | 31.13 | 33.09 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 28.53 | 22.72 | 24.33 | 27.84 |
| Earning Retention Ratio (%) | 0.00 | 64.07 | 71.60 | 68.87 | 66.91 |
| Cash Earning Retention Ratio (%) | 0.00 | 71.47 | 77.28 | 75.67 | 72.16 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 209.62 | 91.24 | 21.07 | 19.57 | 113.79 |
| Interest Coverage Ratio (Post Tax) (%) | 133.25 | 57.24 | 13.47 | 12.37 | 76.39 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 32989.12 | 25138.28 | 25860.24 | 15719.76 | 12145.74 |
| EV / Net Operating Revenue (X) | 7.95 | 6.42 | 7.42 | 4.99 | 5.01 |
| EV / EBITDA (X) | 28.25 | 23.49 | 27.68 | 22.28 | 20.84 |
| MarketCap / Net Operating Revenue (X) | 7.99 | 6.45 | 7.35 | 4.84 | 5.02 |
| Retention Ratios (%) | 0.00 | 64.06 | 71.59 | 68.86 | 66.90 |
| Price / BV (X) | 7.97 | 7.36 | 8.76 | 6.15 | 5.70 |
| Price / Net Operating Revenue (X) | 7.99 | 6.45 | 7.35 | 4.84 | 5.02 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
